¹H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adults.

Abstract

To assess whether noninvasive proton magnetic resonance spectroscopy (¹H-MRS) tissue metabolite measurements at baseline can predict an increase in the rate of β-amyloid (Aβ) accumulation on serial PET in clinically normal (CN) older adults. Consecutive participants aged 60 years and older (n = 594) from the Mayo Clinic Study of Aging who were CN at baseline and who underwent ¹H-MRS from the posterior cingulate voxel and longitudinal ¹¹C-Pittsburgh compound B (PiB)-PET were included. The rate of Aβ accumulation by serial cortical PiB standardized uptake value ratios was estimated as a function of baseline ¹H-MRS metabolite ratios and time using mixed-effect models adjusted for age, sex, and <i>APOE</i> ε4. Effect of <i>APOE</i> ε4 on the relationship between baseline MRS and an increased rate of Aβ accumulation was also assessed. Among all participants, a higher myo-inositol (mI)/creatine (<i>p</i> = 0.011) and a lower <i>N</i>-acetylaspartate/mI (<i>p</i> = 0.006) at baseline were associated with an increased Aβ accumulation over time after adjusting for age, sex, and <i>APOE</i> ε4. <i>APOE</i> ε4 did not modify the association of baseline ¹H-MRS metabolite ratios and rate of Aβ accumulation. However, <i>APOE</i> ε4 carriers accumulated Aβ faster than noncarriers regardless of the baseline Aβ load (<i>p</i> = 0.001). Among CN older adults, early metabolic alterations on ¹H-MRS and <i>APOE</i> ε4 status are independently associated with an increased rate of Aβ accumulation. Our findings could have important implications for early diagnosis and identification of individuals for secondary prevention trials, because an increased rate of Aβ accumulation in CN older adults may confer a higher risk for cognitive decline and mild cognitive impairment.